BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 30762787)

  • 1. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Sun Q; Jia Q; Song L; Duan L
    Medicine (Baltimore); 2019 Feb; 98(7):e14513. PubMed ID: 30762787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis.
    Ju X; Jiang Z; Ma J; Yang D
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome.
    Calderon G; Patel C; Camilleri M; James-Stevenson T; Bohm M; Siwiec R; Rogers N; Wo J; Lockett C; Gupta A; Xu H; Shin A
    J Clin Gastroenterol; 2022 Mar; 56(3):234-242. PubMed ID: 33780215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.
    Treem WR; Ahsan N; Kastoff G; Hyams JS
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):280-6. PubMed ID: 8890079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients.
    Sun QH; Liu ZJ; Zhang L; Wei H; Song LJ; Zhu SW; He MB; Duan LP
    J Dig Dis; 2021 May; 22(5):246-255. PubMed ID: 33822477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 7. The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome.
    Tian Z; Zhuang X; Luo M; Yin W; Xiong L
    BMC Gastroenterol; 2020 Mar; 20(1):73. PubMed ID: 32178625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis.
    Luo M; Zhuang X; Tian Z; Xiong L
    BMC Gastroenterol; 2021 Jan; 21(1):14. PubMed ID: 33407171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome.
    Fredericks E; Theunissen R; Roux S
    Turk J Gastroenterol; 2020 Dec; 31(12):840-847. PubMed ID: 33625995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.
    Zhuang X; Li T; Li M; Huang S; Qiu Y; Feng R; Zhang S; Chen M; Xiong L; Zeng Z
    Inflamm Bowel Dis; 2019 Oct; 25(11):1751-1763. PubMed ID: 31498864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Fecal Short Chain Fatty Acids With Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome.
    Waseem MR; Shin A; Siwiec R; James-Stevenson T; Bohm M; Rogers N; Wo J; Waseem L; Gupta A; Jarrett M; Kadariya J; Xu H
    Clin Transl Gastroenterol; 2023 Jan; 14(1):e00541. PubMed ID: 36227781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome.
    Ringel-Kulka T; Choi CH; Temas D; Kim A; Maier DM; Scott K; Galanko JA; Ringel Y
    Am J Gastroenterol; 2015 Sep; 110(9):1339-46. PubMed ID: 26303129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis.
    Gargari G; Mantegazza G; Taverniti V; Gardana C; Valenza A; Rossignoli F; Barbaro MR; Marasco G; Cremon C; Barbara G; Guglielmetti S
    Gut Microbes; 2023 Dec; 15(2):2274128. PubMed ID: 37910479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.
    Gargari G; Taverniti V; Gardana C; Cremon C; Canducci F; Pagano I; Barbaro MR; Bellacosa L; Castellazzi AM; Valsecchi C; Tagliacarne SC; Bellini M; Bertani L; Gambaccini D; Marchi S; Cicala M; Germanà B; Dal Pont E; Vecchi M; Ogliari C; Fiore W; Stanghellini V; Barbara G; Guglielmetti S
    Environ Microbiol; 2018 Sep; 20(9):3201-3213. PubMed ID: 29749705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome.
    Shaidullov IF; Sorokina DM; Sitdikov FG; Hermann A; Abdulkhakov SR; Sitdikova GF
    BMC Gastroenterol; 2021 Jan; 21(1):37. PubMed ID: 33499840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of
    Chen L; Xu WL; Pei LX; Wu XL; Geng H; Guo J; Sun JH
    Zhongguo Zhen Jiu; 2021 Feb; 41(2):137-41. PubMed ID: 33788460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
    El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.
    Tanaka Y; Yamashita R; Kawashima J; Mori H; Kurokawa K; Fukuda S; Gotoh Y; Nakamura K; Hayashi T; Kasahara Y; Sato Y; Fukudo S
    J Gastroenterol; 2022 Oct; 57(10):748-760. PubMed ID: 35908139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
    Valeur J; Røseth AG; Knudsen T; Malmstrøm GH; Fiennes JT; Midtvedt T; Berstad A
    Digestion; 2016; 94(1):50-6. PubMed ID: 27487397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.